RGC

RGC Regencell Bioscience Holdings Limited

Stock · NasdaqCM · Hong Kong · Healthcare · KYG7487R1002

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Regencell Bioscience Holdings Limited, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 5.27 USD 0.00%

52-week range 4.51 – 69.00

Dividend yield—

Market cap2.6B

NowoTrade score 18 Grade C

Price history

Daily prices in USD.

Updated 08 Nov 2026 14:26. Information, not advice.

Results

Next results 06 May 2027 in 179 days · 17:00

Last results —Nothing reported yet

Beat the estimate —

Average surprise — reported against the estimate, last 0 quarters

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
06 May 2027 17:00	—	—	—	Upcoming
28 Oct 2026 16:00	—	—	—	—
15 Jun 2026 16:00	—	—	—	—
18 Nov 2025 16:00	—	—	—	—
16 Jul 2025 16:00	—	—	—	—

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2026	0	—	-11.7M	—	—	—	-7.7M
2025	—	—	—	—	-0.01	+17.2%	—
2024	0	—	-4.3M	—	-0.01	+26.9%	-4M
2023	0	—	-5.9M	—	-0.01	+22.0%	-5M
2022	0	—	-7.4M	—	-0.02	—	-6M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by day
Period	Opening price	High	Low	Closing price	Change	Volume
06 Apr 2023	0.7142	0.7142	0.7142	0.7142	+0.89%	3,800
05 Apr 2023	0.7316	0.7408	0.7079	0.7079	-9.97%	79,800
04 Apr 2023	0.7529	0.7863	0.7055	0.7863	+15.46%	114,000
03 Apr 2023	0.6811	0.6811	0.6811	0.6811	0.00%	—
31 Mar 2023	0.6811	0.6811	0.6811	0.6811	-1.52%	15,200
30 Mar 2023	0.6916	0.6916	0.6916	0.6916	0.00%	—
29 Mar 2023	0.7547	0.7547	0.6916	0.6916	-1.57%	30,400
28 Mar 2023	0.6700	0.7355	0.6700	0.7026	+5.83%	34,200
27 Mar 2023	0.6639	0.6639	0.6639	0.6639	-2.17%	3,800
24 Mar 2023	0.6787	0.6787	0.6787	0.6787	-4.13%	3,800
23 Mar 2023	0.7079	0.7079	0.7079	0.7079	0.00%	—
22 Mar 2023	0.7079	0.7079	0.7079	0.7079	0.00%	3,800
21 Mar 2023	0.7079	0.7079	0.7079	0.7079	0.00%	3,800
20 Mar 2023	0.7079	0.7079	0.7079	0.7079	0.00%	—
17 Mar 2023	0.7079	0.7079	0.7079	0.7079	0.00%	—
16 Mar 2023	0.7079	0.7079	0.7079	0.7079	+1.51%	7,600
15 Mar 2023	0.6974	0.6974	0.6974	0.6974	0.00%	3,800
14 Mar 2023	0.6974	0.6974	0.6974	0.6974	0.00%	—
13 Mar 2023	0.6974	0.6974	0.6974	0.6974	0.00%	3,800
10 Mar 2023	0.6974	0.6974	0.6974	0.6974	+0.91%	15,200
09 Mar 2023	0.6911	0.6911	0.6911	0.6911	-0.94%	11,400
08 Mar 2023	0.7113	0.7129	0.6842	0.6976	-11.49%	76,000
07 Mar 2023	0.7882	0.7882	0.7882	0.7882	+14.27%	7,600
06 Mar 2023	0.6897	0.6897	0.6897	0.6897	-0.08%	3,800
03 Mar 2023	0.7208	0.7208	0.6903	0.6903	-5.31%	15,200

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Regencell (RGC) Stock Looks Rich As DOJ Probe Raises Questions (opens in a new tab) Simply Wall St. · 25 Oct 2026 08:10
How Investors Are Reacting To Regencell Bioscience Holdings (RGC) Wider Full Year Loss (opens in a new tab) Simply Wall St. · 17 Oct 2026 16:10
Is Regencell Bioscience Holdings (RGC) Fully Priced After Its Annual Loss Deepened? (opens in a new tab) Simply Wall St. · 08 Oct 2026 15:13

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 5.27 USD
Market cap: 2.6B
Exchange: NasdaqCM
Country: Hong Kong
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Currency: USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the score	Points	Why
Business growth Yearly growth of revenue and of earnings per share.	8.8 / 25 No figures for this part: it counts as a cautious 35%.	—
Quality Return on equity, net margin and how stable the margins are.	0.0 / 25	ROE of -129%
Financial strength Net debt against operating earnings, interest cover and free cash flow.	9.6 / 20	Free cash flow yield of -0.1%
Valuation Free cash flow yield and the P/E against its sector.	0.0 / 15	—
Analysts How far the analysts' average target is from today's price.	3.5 / 10 No figures for this part: it counts as a cautious 35%.	—

Score capped at 60: free cash flow was negative in two of the last three years
The last full year was a loss

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 60% of the figures (grade C). Warnings take 6 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
Figure	Value	Reading	Sector median
Price / book	195.19×	Weak	3.81×
EV / EBITDA	-223.25×	Weak	12.63×
Free cash flow yield	-0.1%	Weak	2.6%

Quality
Figure	Value	Reading	Sector median
Gross margin	0%	Weak	58.6%
Operating margin	0%	Weak	7.8%
Net margin	0%	Weak	2.8%
Return on equity	-128.5%	Weak	5.7%
Return on assets	-71.5%	Weak	3.6%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	0.02×	Good	0.48×
Current ratio	10.77×	Good	2.35×

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow RGC and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in